Category : Search result: Natasha Dalal


Gold Rally vs Jewellery Stocks: A Sharp Divergence

Gold prices have surged over 70% in a year, yet 8 of the top 10 jewellery stocks are in the red. Analysts explain the disconnect and reveal which stocks to watch. Read more for expert insights.

December IPO Boom: 15 New Listings Defy Market Swings

Despite stock market volatility, 15 companies launched IPOs last week. Discover which stocks soared and which stumbled on debut, with December listings set to hit 50. Read for key investment insights.

2025 IPO Boom: 50% Listings Below Issue Price

Despite strong investor demand, nearly half of 2025's mainboard IPOs are trading below their issue price. Discover which stocks soared and which sank, and what this means for retail investors.

Sensex jumps 450 pts on RBI's surprise rate cut

The RBI's unexpected 25 bps rate cut fueled a 450-point surge in the Sensex to 85,712. Banking and rate-sensitive stocks led the rally. Experts see positive market consolidation ahead.

Nifty 50 Soars to New Record High of 26,310

After 14 months, the Nifty 50 surged to a fresh record high of 26,310, driven by government stimulus, strong earnings outlook, and renewed foreign investor interest. Discover the factors behind the bull run and expert targets.

Sensex Jumps 1,022 Points, Nears All-Time High

The Sensex surged 1,022 points, driven by global market rallies and expectations of US and Indian rate cuts. Discover the factors behind this massive rally and what's next for investors.

Small-Cap Stocks Crash 60% in 2025 Market Rout

Nifty Smallcap 100 index drops 6% in 2025 as poor earnings and rich valuations trigger massive selloff. Tejas Networks, FirstCry among top losers falling 40-60%. Discover why investors are shifting to large-caps.

Integrated Industries Shares Hit 5% Upper Circuit

Integrated Industries stock surges 16% in 3 days, hitting upper circuit after Q2 net profit jumps 104% to ₹29.9 crore. Revenue up 54%, EBITDA doubles. Discover the full financial analysis.

Balaxi Pharma Soars 10% Despite 47% Yearly Loss

Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.

Groww IPO Makes Strong 14% Debut on Dalal Street

Groww shares surged 14% in their market debut, exceeding grey market expectations. Experts advise on whether to book profits or hold for long-term growth in India's booming fintech sector.

BSE Share Price Jumps 7% - Buy Signal?

BSE shares skyrocket 7% while Dalal Street remains muted. Expert analysis reveals whether this surge signals a buying opportunity or temporary spike.

Multibagger Stock Rallies 1750% in 5 Years

Discover how Waaree Renewables Technologies became a multibagger sensation, delivering staggering returns while defying broader market trends. Learn why this renewable energy stock continues to attract investor attention.

Studds IPO Listing Tomorrow: GMP Signals Strong Debut

Studds Accessories gears up for its highly anticipated stock market listing tomorrow. With grey market premium signaling robust investor appetite, discover what to expect from this helmet manufacturer's Dalal Street entry and key details every investor sh

Lenskart IPO: Will $5B Valuation Spoil Dalal Street Party?

As Lenskart eyes a massive $4-5 billion IPO valuation, market experts question if the eyewear giant's ambitious pricing could dampen its stock market debut. Discover the risks and opportunities facing India's hottest unicorn.

Page 2 of 3